Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray for Preoperative Sedation in General Anesthesia Abdominal Surgery
CTR20182153Phase 2Terminated
- Sponsor
- Hengrui Therapeutics
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in conscious sedation, sponsored by Hengrui Therapeutics. Started Dec 2018; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
conscious sedation
Beyond the preview
Go deeper on CTR20182153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182153.